Document is current
Any future updates will be listed below
-
Authors
Brenner, Steffen
Schilling, Achim
Krauss, Patrick
Mohamed, Sherif
Fauth, Julia
Niroomand, Zohair
Kinfe, Thomas Mehari https://orcid.org/0000-0002-4888-543X
- License Information
-
More Information
Article History
Received: 17 January 2026
Accepted: 13 April 2026
First Online: 4 May 2026
Declarations
:
: Thomas Mehari Kinfe, MD, PhD, works as a consultant for Abbott Inc. and has been paid for presentation and received conference travel support from Abbott Inc. Thomas Mehari Kinfe is the founder and CEO of NAGUS Consulting and is an Editorial Board member of Pain and Therapy. Thomas Mehari Kinfe was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Steffen Brenner has nothing to disclose. Achim Schilling has nothing to disclose. Patrick Krauss has nothing to disclose. Sherif Mohamed has nothing to disclose. Julia Fauth has nothing to disclose. Zohair Niroomand has nothing to disclose.
: The study protocol was approved by an independent internal local ethics committee (IRB No. 2024-671), conducted in accordance with the principles of the latest revision of the Declaration of Helsinki, and registered on January 21, 2025, in the German Clinical Trials Register (DRKS ID: DRKS00035826). Written informed consent was obtained from all participants.
